Magnetic Resonance - Technology Information Portal Welcome to MRI Technology••


The impact of TTIP/TPP on the MRI scanner market will bring :
more variety 
better scanners 
more risk 
less regulation 
cheaper scanners 
Lost in Translation 
no change at all 

MRI News Service:
'Nephrogenic Systemic Fibrosis'
Result: Searchterm 'Nephrogenic Systemic Fibrosis' found in 8 news
Result Pages
More Results: Database  (13)  Forum  (1)  
News Refinements:  Contrast Agents  Devices  Financial  
FDA: New warnings required on use of gadolinium-based contrast agents
''''The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF), if the drug is ...'
Thursday, 9 September 2010   by
European Medicines Agency makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents
''''The European Medicines Agency (EMEA) has adopted a set of recommendations aimed at minimising the risk of nephrogenic systemic fibrosis (NSF) with gadolinium-containing contrast agents in patients at risk of developing the ...'
Friday, 20 November 2009   by
Questions and Answers on Gadolinium-Based Contrast Agents
''''Since December 2006, FDA has continued to investigate reports of nephrogenic systemic fibrosis (NSF) in patients who received gadolinium-based contrast agents (GBCAs) to help define risk factors for NSF. In addition, the FDA has requested the ...'
Friday, 9 January 2009   by
Editorial - Association of Gadolinium Based Magnetic Resonance Imaging Contrast Agents and Nephrogenic Systemic Fibrosis
''''While nephrogenic systemic fibrosis (NSF) following exposure to gadolinium based MRI contrast agents (GBMCA) is a rare disorder, its long-term effects are devastating to patients with renal insufficiency. As a consequence, this study is now refused by ...'
Wednesday, 15 October 2008   by
NSF-Active and NSF-Inert Species of Gadolinium: Mechanistic and Clinical Implications
''''The understanding of the pathogenesis of nephrogenic systemic fibrosis (NSF) and its link with gadolinium-containing contrast agents is still in an early stage. The studies by Wiginton et al. [1] and Golding and Provenzale [2] in the April 2008 issue of ...'
Friday, 27 June 2008   by
Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis
''''Nephrogenic systemic fibrosis (NSF), described in 2000 (1), is an emerging systemic disorder characterized by widespread tissue fibrosis. Originally known as nephrogenic fibrosing dermopathy because of its dominant cutaneous findings, the nomenclature ...'
Thursday, 1 March 2007   by
MRI contrast agent linked to rare disease
''''OAK BROOK, Ill. (January 25, 2007) ? New research has shown a possible association between a popular magnetic resonance imaging (MRI) contrast agent and the incidence of a rare disease called nephrogenic systemic fibrosis (NSF) in patients with kidney ...'
Thursday, 25 January 2007   by
Nephrogenic systemic fibrosis
''''Nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy is a rare and serious syndrome that involves fibrosis of skin, joints, eyes, and internal organs. Its cause is not fully understood, but it seems to be associated with exposure to ...'
News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
If this is coffee, please bring me some tea; but if this is tea, please bring me some coffee.
- Abraham Lincoln
Share This Page

Forgot your UserID/Password ?  

      Ups uses cookies! By browsing, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • 
Copyright © 2003 - 2018 SoftWays. All rights reserved. [ 23 May 2019]
Terms of Use | Privacy Policy | Advertising
 [last update: 2018-03-08 05:11:00]